注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Glaukos Corp是一家眼科醫療技術和製藥公司。該公司專注於開發治療青光眼、角膜疾病和視網膜疾病的新療法。其候選產品包括微創青光眼手術(MIGS)產品,其中包括插入微型裝置或藥物輸送系統,旨在通過恢復青光眼和MIGS患者的自然房水流出途徑來降低眼內壓(IOP)測量眼內壓力的生物傳感器;為受角膜擴張障礙(如圓錐角膜或屈光障礙)影響的患者強化、穩定和重塑角膜的生物活性藥物;適用於眼瞼並設計用於治療乾眼症、老花眼、青光眼和其他眼表疾病和病症的透皮藥物;微創、生物可腐蝕的緩釋藥物輸送植入物,以改善患者的視力。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Thomas W. Samuelson | - | - | Member of Scientific Advisory Board |
Richard L. Lindstrom | 74 | - | Member of Scientific Advisory Board |
Gilbert H. Kliman | 63 | 2020 | Independent Director |
Ike K. Ahmed | - | - | Member of Scientific Advisory Board |
Kerry D. Solomon | - | - | Member of Scientific Advisory Board |
Richard A. Lewis | - | - | Member of Scientific Advisory Board |
Eric D. Donnenfeld | 66 | - | Member of Scientific Advisory Board |
Edward J. Holland | - | - | Member of Scientific Advisory Board |
Leana S. Wen | 39 | 2021 | Independent Director |
Mark J. Foley | 57 | 2014 | Lead Independent Director |
Denice M. Torres | 62 | 2021 | Independent Director |
Kuldev Singh | - | - | Member of Scientific Advisory Board |
John Berdahl | - | - | Member of Scientific Advisory Board |
Robert J. Cionni | - | - | Member of Scientific Advisory Board |
Aimee S. Weisner | 53 | 2014 | Independent Director |
Thomas William Burns | 61 | 2002 | Chairman & CEO |
Marc A. Stapley | 53 | 2014 | Independent Director |
David Frank Hoffmeister | 68 | 2014 | Independent Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核